MEDIBIOTIX LIMITED

Active Newcastle Upon Tyne

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
M

MEDIBIOTIX LIMITED

Research and experimental development on biotechnology

Founded 17 Jun 2020 Active Newcastle Upon Tyne, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 25 Mar 2026 Next due 31 Mar 2026 29 days overdue
Confirmation Submitted 16 Jun 2025 Next due 30 Jun 2026 2 months remaining
Net assets £1 £0 2024 year on year
Total assets £1 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Core Bath Lane Newcastle Helix Newcastle Upon Tyne NE4 5TF United Kingdom

Full company profile for MEDIBIOTIX LIMITED (12676346), an active company based in Newcastle Upon Tyne, United Kingdom. Incorporated 17 Jun 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.00

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Simon Jonathan HewitsonDirectorBritishUnited Kingdom5028 Apr 2025Active

Shareholders

Shareholders (1)

Skinbiotherapeutics Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 17 Jun 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MEDIBIOTIX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
20 Mar 2026OfficersAppointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026
13 Feb 2026OfficersTermination of Stuart Ashman as director on 13 Feb 2026
14 Jan 2026OfficersAppointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026
30 Sept 2025OfficersTermination of Simon Jonathan Hewitson as director on 30 Sept 2025
25 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

20 Mar 2026 Officers

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

13 Feb 2026 Officers

Termination of Stuart Ashman as director on 13 Feb 2026

14 Jan 2026 Officers

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

30 Sept 2025 Officers

Termination of Simon Jonathan Hewitson as director on 30 Sept 2025

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 25 Mar 2026

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

1 months ago on 20 Mar 2026

Termination of Stuart Ashman as director on 13 Feb 2026

2 months ago on 13 Feb 2026

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

3 months ago on 14 Jan 2026

Termination of Simon Jonathan Hewitson as director on 30 Sept 2025

7 months ago on 30 Sept 2025